Latest filing published 04 Jan 2023 for Oyster Point Pharma, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Mark Anthony Murray appears in our data through filings on Oyster Point Pharma, Inc. shares, published by SEC (Form 4). The record holds 6 filings, for trades running from 4 November 2019 to 3 January 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 4 January 2023 with a transaction in Oyster Point Pharma, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations